Dr. Szeja on Adjuvant Radiation Therapy After Lumpectomy in Elderly Patients With TNBC

Sean Szeja, MD
Published: Saturday, Sep 26, 2015



Sean Szeja, MD, radiation oncologist, University of Texas Medical Branch, discusses outcomes associated with adjuvant radiation therapy following lumpectomy for elderly patients with triple-negative breast cancer (TNBC).

A recent retrospective analysis of the SEER database looked at 974 female patients over the age of 70 with early-stage TNBC who had lumpectomy with adjuvant radiation therapy compared with lumpectomy alone, Szeja explains.

Data showed that patients who received adjuvant radiation therapy following lumpectomy had improved overall survival and breast cancer-specific survival (HR, .14). This translates to a one-sixth decrease in death from breast cancer, Szeja says.


Sean Szeja, MD, radiation oncologist, University of Texas Medical Branch, discusses outcomes associated with adjuvant radiation therapy following lumpectomy for elderly patients with triple-negative breast cancer (TNBC).

A recent retrospective analysis of the SEER database looked at 974 female patients over the age of 70 with early-stage TNBC who had lumpectomy with adjuvant radiation therapy compared with lumpectomy alone, Szeja explains.

Data showed that patients who received adjuvant radiation therapy following lumpectomy had improved overall survival and breast cancer-specific survival (HR, .14). This translates to a one-sixth decrease in death from breast cancer, Szeja says.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Medical Crossfire®: Clinical Updates on PARP Inhibition and its Evolving Use in the Treatment of CancersMay 30, 20181.5
Publication Bottom Border
Border Publication
x